1. The Road to Quality Improvement in HER2-Positive Breast Cancer

3. Program Goals

4. What Is Quality Improvement?

5. QI and HER2-positive Breast Cancer

6. Defining HER2-positive Status

7. Importance of Accuracy

8. Metastatic Disease and Testing

9. Treatment Guidelines for Metastatic HER2 Disease in the First-line Setting

10. Results of the CLEOPATRA Trial

11. Recommendations for Duration of Therapy

12. Treatment for Patients Who Are HER2-positive and HR-positive

13. Recommendations for Progression

14. Results of the EMILIA Trial

15. Related Issues

16. Brain Metastases: ASCO Guidelines

17. Abbreviations

18. Abbreviations (cont)

19. References

20. References (cont)

21. References (cont)

22. References (cont)

23. References (cont)